NFKB1 and breast carcinoma: DHX15 can interact with circRNF10 to isolate DHX15 from p65 and inhibit the progression of breast cancer by inhibiting the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway63.